Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis.

IF 4.3 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY World Journal of Gastroenterology Pub Date : 2024-09-21 DOI:10.3748/wjg.v30.i35.3996
Zhen-Hua Fu, Zi-Yue Zhao, Yao-Bing Liang, Dong-Yu Cheng, Jian-Ming Luo, Hai-Xing Jiang, Shan-Yu Qin
{"title":"Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis.","authors":"Zhen-Hua Fu, Zi-Yue Zhao, Yao-Bing Liang, Dong-Yu Cheng, Jian-Ming Luo, Hai-Xing Jiang, Shan-Yu Qin","doi":"10.3748/wjg.v30.i35.3996","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of hypertriglyceridemia (HTG)-induced acute pancreatitis (AP) is steadily increasing in China, becoming the second leading cause of AP. Clinical complications and outcomes associated with HTG-AP are generally more severe than those seen in AP caused by other etiologies. HTG-AP is closely linked to metabolic dysfunction and frequently coexists with metabolic syndrome or its components. However, the impact of metabolic syndrome components on HTG-AP clinical outcomes remains unclear.</p><p><strong>Aim: </strong>To investigate the impact of metabolic syndrome component burden on clinical outcomes in HTG-AP.</p><p><strong>Methods: </strong>In this retrospective study of 255 patients diagnosed with HTG-AP at the First Affiliated Hospital of Guangxi Medical University, we collected data on patient demographics, clinical scores, complications, and clinical outcomes. Subsequently, we analyzed the influence of the presence and number of individual metabolic syndrome components, including obesity, hyperglycemia, hypertension, and low high-density lipoprotein cholesterol (HDL-C), on the aforementioned parameters in HTG-AP patients.</p><p><strong>Results: </strong>This study found that metabolic syndrome components were associated with an increased risk of various complications in HTG-AP, with low HDL-C being the most significant risk factor for clinical outcomes. The risk of complications increased with the number of metabolic syndrome components. Adjusted for age and sex, patients with high-component metabolic syndrome had significantly higher risks of renal failure [odds ratio (OR) = 3.02, 95%CI: 1.12-8.11)], SAP (OR = 5.05, 95%CI: 2.04-12.49), and intensive care unit admission (OR = 6.41, 95%CI: 2.42-16.97) compared to those without metabolic syndrome.</p><p><strong>Conclusion: </strong>The coexistence of multiple metabolic syndrome components can synergistically worsen the clinical course of HTG-AP, making it crucial to monitor these components for effective disease management.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 35","pages":"3996-4010"},"PeriodicalIF":4.3000,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438666/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v30.i35.3996","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The incidence of hypertriglyceridemia (HTG)-induced acute pancreatitis (AP) is steadily increasing in China, becoming the second leading cause of AP. Clinical complications and outcomes associated with HTG-AP are generally more severe than those seen in AP caused by other etiologies. HTG-AP is closely linked to metabolic dysfunction and frequently coexists with metabolic syndrome or its components. However, the impact of metabolic syndrome components on HTG-AP clinical outcomes remains unclear.

Aim: To investigate the impact of metabolic syndrome component burden on clinical outcomes in HTG-AP.

Methods: In this retrospective study of 255 patients diagnosed with HTG-AP at the First Affiliated Hospital of Guangxi Medical University, we collected data on patient demographics, clinical scores, complications, and clinical outcomes. Subsequently, we analyzed the influence of the presence and number of individual metabolic syndrome components, including obesity, hyperglycemia, hypertension, and low high-density lipoprotein cholesterol (HDL-C), on the aforementioned parameters in HTG-AP patients.

Results: This study found that metabolic syndrome components were associated with an increased risk of various complications in HTG-AP, with low HDL-C being the most significant risk factor for clinical outcomes. The risk of complications increased with the number of metabolic syndrome components. Adjusted for age and sex, patients with high-component metabolic syndrome had significantly higher risks of renal failure [odds ratio (OR) = 3.02, 95%CI: 1.12-8.11)], SAP (OR = 5.05, 95%CI: 2.04-12.49), and intensive care unit admission (OR = 6.41, 95%CI: 2.42-16.97) compared to those without metabolic syndrome.

Conclusion: The coexistence of multiple metabolic syndrome components can synergistically worsen the clinical course of HTG-AP, making it crucial to monitor these components for effective disease management.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
代谢综合征成分对高甘油三酯血症诱发的急性胰腺炎临床结果的影响。
背景:在中国,高甘油三酯血症(HTG)诱发急性胰腺炎(AP)的发病率正在稳步上升,已成为急性胰腺炎的第二大病因。与其他病因引起的急性胰腺炎相比,高甘油三酯血症引起的急性胰腺炎的临床并发症和预后通常更为严重。HTG-AP 与代谢功能障碍密切相关,经常与代谢综合征或其组成部分同时存在。然而,代谢综合征成分对 HTG-AP 临床预后的影响仍不清楚。目的:研究代谢综合征成分负担对 HTG-AP 临床预后的影响:在这项回顾性研究中,我们收集了广西医科大学第一附属医院确诊的255例HTG-AP患者的人口统计学、临床评分、并发症和临床结局数据。随后,我们分析了肥胖、高血糖、高血压和低高密度脂蛋白胆固醇(HDL-C)等代谢综合征个体成分的存在和数量对 HTG-AP 患者上述指标的影响:该研究发现,代谢综合征与 HTG-AP 患者各种并发症风险的增加有关,而低高密度脂蛋白胆固醇是影响临床结果的最重要风险因素。并发症的风险随着代谢综合征成分的增加而增加。经年龄和性别调整后,与无代谢综合征的患者相比,高代谢综合征患者发生肾衰竭[几率比(OR)=3.02,95%CI:1.12-8.11]、SAP(OR=5.05,95%CI:2.04-12.49)和入住重症监护室(OR=6.41,95%CI:2.42-16.97)的风险明显更高:结论:多种代谢综合征并存会协同恶化 HTG-AP 的临床病程,因此监测这些代谢综合征对有效控制疾病至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
World Journal of Gastroenterology
World Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
7.80
自引率
4.70%
发文量
464
审稿时长
2.4 months
期刊介绍: The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
期刊最新文献
Advances in artificial intelligence for predicting complication risks post-laparoscopic radical gastrectomy for gastric cancer: A significant leap forward. Comprehensive approach to esophageal variceal bleeding: From prevention to treatment. Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function. Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1